Newsroom

Sorted by: Latest

-

Multiply Labs Announces New Collaboration to Automate Cell Therapy Manufacturing with Robotics

SAN FRANCISCO--(BUSINESS WIRE)--AstraZeneca collaborates with Multiply Labs to scale cell therapy manufacturing using end-to-end GMP-ready robotic technology....
-

Arc’teryx任命Avery Baker出任品牌長

卑詩省北溫哥華--(BUSINESS WIRE)--(美國商業資訊)-- 專注於高性能機能服飾與裝備的全球設計公司Arc’teryx Equipment今日宣布,任命Avery Baker為公司首位品牌長(Chief Brand Officer)。此一全新設立的高階主管職位,象徵Arc’teryx在全球品牌發展歷程中的重要一步。Baker加入之際,Arc’teryx正持續釋放其品牌潛力、提升全球品牌能力,並在北美、EMEA(歐洲、中東與非洲地區)、APAC(亞太)及大中華區推動長期成長。同時,Tobia Prevedello獲任命為EMEA總經理。Prevedello擁有超過20年的國際領導經驗,長期深耕EMEA與APAC市場。 身為品牌長,Baker將直接向執行長Stuart Haselden匯報,負責全球品牌策略、行銷與品牌溝通,並領導打造業界領先的消費者體驗團隊。Baker將從集團整體層級,與全球及各區域領導團隊緊密合作,推動品牌願景——為世界各地的山岳運動者打造頂尖的單雙板滑雪、越野與攀登裝備,並突破垂直戶外產業的傳統運作模式。此項任命,是持續推進全球品牌成長、深化消費者連結,...
-

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Resideo Technologies, Inc. (NYSE: REZI)

NEW YORK--(BUSINESS WIRE)--Spruce Point Capital Management, LLC (“Spruce Point” or “we” or “us”), a New York-based investment management firm that focuses on forensic research and short-selling, today issued a detailed report entitled “Red Alert, Where There’s Smoke, There’s Fire” that outlines why we believe and estimate that shares of Resideo Technologies, Inc. (NYSE: REZI) (“REZI” or the “Company”) face up to 25% – 50% potential long-term downside to approximately $17.64 – $26.45 per share,...
-

New Global CDO Report Reveals Data Governance and AI Literacy as Key Accelerators in AI Adoption

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Informatica from Salesforce, a leader in enterprise AI-powered cloud data management, has published a new global study titled “CDO Insights 2026: Data governance and the trust paradox of data and AI literacy take center stage”. The study found that while organizations are rapidly accelerating their use of AI, many face challenges with data readiness, data and AI literacy, required to realize the full value of their AI investments. The study, which surveyed...
-

Clearwater Analytics integriert KI in die Beacon Risk Platform, um die Modellvalidierung und Risikoanalyse zu beschleunigen

BOISE, Idaho & CHICAGO & NEW YORK & LONDON & HONGKONG--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN), die umfassendste Technologieplattform für das Investitionsmanagement, hat heute bahnbrechende integrierte agentenbasierte KI-Funktionen innerhalb von Beacon by CWAN, seiner Plattform für Unternehmensrisiken und quantitative Analysen, angekündigt, die es Risikoteams ermöglichen, die Modellvalidierung, die Risikoanalyse und die Entscheidungsfindung zu beschleunigen. Angesichts der zunehmende...
-

MIKROE Signs Multi-Year MCU Embedded Development Tool Support Deal With Renesas

BELGRADE, Serbia--(BUSINESS WIRE)--MIKROE, the embedded solutions company that dramatically cuts development time by providing innovative hardware and software products based on proven standards, has signed a multi-year MCU development tool support deal with Renesas Electronics Corporation, a global semiconductor solution provider headquartered in Tokyo. The agreement commits MIKROE to providing development tools for 500 of Renesas’ most popular MCUs, plus upcoming new releases. A ‘Planet Debug...
-

Arc'teryx Appoints Avery Baker Chief Brand Officer

NORTH VANCOUVER, British Columbia--(BUSINESS WIRE)--Arc'teryx Equipment, the global design company specializing in technical high-performance apparel and equipment, today announced the appointment of Avery Baker as its first-ever Chief Brand Officer, a newly created executive role that marks a significant step in the company’s global evolution. Baker joins Arc’teryx as it continues to unlock brand potential, elevate global capabilities, and fuel long-term growth across North America, EMEA, APAC...
-

Riassunto: Indero CRO e la World Scleroderma Foundation annunciano l’avvio di una collaborazione strategica volta a portare avanti l’intervento terapeutico tempestivo nella sclerosi sistemica

MONTREAL--(BUSINESS WIRE)--Indero annuncia l’inizio di una collaborazione strategica con la World Scleroderma Foundation (WSF) a sostegno del trial di piattaforma WSF SHIELD – uno studio clinico randomizzato, in doppio cieco e con design adattivo progettato per valutare vari prodotti medicinali in fase di sperimentazione in pazienti che soddisfano i criteri VEDOSS. L’obiettivo dello studio è intervenire nelle fasi precocissime della sclerosi sistemica per migliorare gli esiti clinici per pazien...
-

Osmo Publishes More New Fragrance Ingredient Patents Than Entire Industry Combined

NEW YORK--(BUSINESS WIRE)--Osmo Publishes More New Fragrance Ingredient Patents Than Entire Industry Combined...
-

11:11 Systems Announces 2025 Partner Awards for North America

FAIRFIELD, N.J.--(BUSINESS WIRE)--11:11 Systems (“11:11”), a leading managed infrastructure solutions provider, today announced the recipients of its 2025 Partner Awards in North America, the company’s inaugural partner recognition program. The awards spotlight 11:11 partners whose collaboration, technical excellence and customer focus have been instrumental in helping organizations modernize, protect and manage their mission-critical applications and data. The 11:11 Partner Awards recognize or...